VIVES Partners — Full Portfolio

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease.

BiotechHealthtech

FMFrédéric Marrache(Co-founder & CEO)in

Co-investorsJEJeito CapitalSASanofi VenturesSOSofinnova PartnersAPApollo Health VenturesSISixty Degree Capital

3D-Side develops a web-based platform called Customize that connects surgeons, patients, and medical device manufacturers to plan, design, and supervise production of patient-specific medical devices for surgical applications.

Advanced ManufacturingAI & Machine LearningDigital HealthMedical DevicesSaaSBrussels, BE

Axinesis develops CE-marked robotic rehabilitation devices for patients with motor and cognitive disorders across acute and home-care settings.

Digital HealthHealthtechMedical DevicesRobotics

JSJulien Sapin(Founder & CTO)inPVPieter Van den Steen(CEO)in

Co-investorsNINivelinvest

BioCsol develops engineered formulations combining active compounds with complementary mechanisms of action for agricultural use, delivering biodegradable solutions that protect soil health while preventing resistance.

AgTechBiotechCircular EconomyCleantechLouvain-la-Neuve, BE

DPDenis Payenin

Co-investorsAGAgri Investment Fund

Botalys develops a platform for creating rare botanical ingredients tailored for nutraceutical and cosmetic applications through structured co-development partnerships with industry leaders.

AgTechBiotechDeep TechHealthtechWellness & FitnessBelgium, BE

Pierre-Antoine Mariage(CEO & Co-founder)

Co-investorsAIAir Liquide Venture Capital (ALIAD)MIMirovaTHThe Yield LabTHThe Yield Lab Europe

e-peas develops energy harvesting power management ICs (ambient energy managers) and low-power microcontrollers that improve the autonomy of intelligent devices for markets including smart home, consumer electronics, and industrial IoT.

EnergyHardwareIoTSemiconductorsLouvain-la-Neuve, BE

GGGeoffroy Gosset(CEO & Co-founder)inJDJulien De Vos(CTO & Co-founder)inCFChristian Ferrier(CMO - Chief Marketing Officer)inCBCoralie Brancart(CFO - Chief Financial Officer)ALAbdelali Lotfi(Sr VP Operations and Global Supply)

Co-investorsNINivelinvestAIAirbus VenturesCRCrédit Mutuel EquityWAWallonie EntreprendreOTOtium CapitalWIWING by Digital Wallonia

Eligo Bioscience is a genetic engineering company pioneering synthetic biology approaches using CRISPR and phage biology to develop therapeutics.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

David Bikard(Scientific Founder)Benoit Barteau(Scientific Cofounder)Nessan Bermingham(Scientific Cofounder)Laia Crespo-Martin(Scientific Cofounder)Xavier Duportet(CEO)

Co-investorsAGAgoranovNSNSG VenturesSASanofi Ventures

ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations.

BiotechDeep TechDigital HealthHealthtechMedical DevicesGhent, BE

Xavier Saelens(Scientific Founder)Nico Callewaert(Scientific Founder)inMike Garrett(Chief Executive Officer)

Co-investorsV-V-Bio VenturesSASambrinvestUCUCB VenturesVIVIBFUFund+

Generare is building a library of naturally evolved molecules by reading and analyzing biological chemistry that has not been previously studied.

AI & Machine LearningBiotech

Co-investorsAGAgoranovDADaphniGAGalion.exeTETeampact.venturesALAlven

Keemotion provides automated video capture and analysis technology for sports teams to record and analyze game performance through comprehensive analytics and scouting tools.

AI & Machine LearningCloud ComputingMedia & EntertainmentSaaSSports Tech

Co-investorsR/R/GA VenturesELElysian Park Ventures

Axoneurotech develops neural engineering technology using a biology-first approach at the intersection of biology and engineering.

BiotechDeep TechMedical Devices

Co-investorsFIFifty Years

Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.

BiotechDeep TechHealthtechMedical DevicesLouvain, BE

DDDr. Denis Dufrane(Founder & Professor)in

BoardEric Paul Pâques(Chairman)

Co-investorsNENew Science VenturesFUFund+SASambrinvestWAWallonie Entreprendre

Nuclidium develops copper-based radioligand therapeutics and diagnostics for cancer treatment and diagnosis, with programs targeting prostate and breast cancer using Copper-61 and Copper-67 isotopes.

BiotechDeep TechHealthtechMedical DevicesBasel, CH

Leila Jaafar(CEO)Gustav(Medical Advisor)

Co-investorsANAngelini VenturesDEDeepTech & Climate FondsKUKurma PartnersNENeva Sgr.

The Akkermansia Company produces a consumer dietary supplement containing proprietary Akkermansia MucT™ bacteria formulated to support weight management, glucose metabolism, gut health, and immune function.

BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness

Muriel DerrienWMWillem M. de Vos(Chair of Microbiology, Wageningen University)

Co-investorsINInnovation IndustriesSESeventure Partners

Viridaxis produces parasitoids for organic and integrated crop protection, serving agricultural customers seeking sustainable pest management solutions.

AgTechBiotechClimate TechGosselies, BE

Vocsens develops a gas sensor product called Envicam-30 that uses semiconductor technology with ultra-low power consumption and a matrix of 16 sensing material spots, addressing the cost and maintenance challenges of traditional gas sensing systems.

CleantechDeep TechHardwareIoTSemiconductorsLouvain-la-Neuve, BE

Laurent Francis(Prof.)Denis Flandre(Prof.)Jean-Pierre Raskin(Prof.)

Co-investorsAGAgri Investment FundAIAIF